Background: Group A Streptococci (GAS) may cause infections of the pharynx and soft tissues and invasive infections in children (iGAS). A significant increase in severe iGAS infections has been reported in Europe since the fall of 2022.

Objectives: This retrospective study aims to analyse clinical data of children with invasive and non-invasive GAS infections in the post-COVID-19 pandemic era, searching for predisposing factors to developing invasive infections.

Methods: History and clinical data of patients hospitalised due to or with coexisting GAS infections were analysed. iGAS and non-iGAS infections were compared.

Results: The cohort comprised 45 children (median age 7 years). 31(69 %) children developed iGAS infections - sepsis with toxic shock syndrome (TSS) (4 children-13 %), deep soft tissue infections (3-10 %), meningitis (2-6 %), pneumonia (2-6 %) or respiratory tract infections - sinusitis or otitis (4-12 %). iGAS children developed complications more frequently (100 % vs 21 %, p < 0.0001) and required prolonged treatment (median 15 vs 10 days, p = 0.0001). Preceding or coexisting viral infections were more common in iGAS children (87 % vs 14 %; p < 0.0001). CRP and PCT were significantly higher in the iGAS group (median 17.95 vs 3.97 mg/dl, p = 0.0002; 6.8 vs 0.05 ng/ml, p = 0.0001, respectively). The multiple logistic regression revealed that preceding or coexisting viral infections and the rise in CRP level increased the risk of iGAS infections. The CRP cut-off > 14.94 mg/dl showed 68.2 % sensitivity (CI 45.13-86.14 %) and 100 % specificity (69.15-100 %).

Conclusion: Our study shows increased incidence and severity of GAS infections among hospitalised children. Previous or coexisting viral infections and CRP with cut-off > 14.94 mg/dl were significant risk factors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiph.2024.102622DOI Listing

Publication Analysis

Top Keywords

gas infections
12
infections
10
post-covid-19 pandemic
8
igas infections
8
clinical data
8
children developed
8
children
5
igas
5
invasive
4
invasive group
4

Similar Publications

Background: Group A Streptococci (GAS) may cause infections of the pharynx and soft tissues and invasive infections in children (iGAS). A significant increase in severe iGAS infections has been reported in Europe since the fall of 2022.

Objectives: This retrospective study aims to analyse clinical data of children with invasive and non-invasive GAS infections in the post-COVID-19 pandemic era, searching for predisposing factors to developing invasive infections.

View Article and Find Full Text PDF

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.

Liver Int

January 2025

Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología (CNM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Background And Aims: In response to direct-acting antivirals (DAAs) therapy, patients who experience a decrease in hepatic venous pressure gradient (HVPG) considerably reduce liver complications and have increased survival. This study aimed to assess the metabolomic changes associated with the changes in HVPG from the start of DAA therapy until 48 weeks after effective DAA therapy in patients with advanced HCV-related cirrhosis.

Methods: We carried out a multicenter longitudinal study in 31 patients with advanced hepatitis C virus (HCV)-related cirrhosis.

View Article and Find Full Text PDF

Ensuring prompt and precise identification of bacterial pathogens is essential for initiating appropriate antibiotic therapy and combating severe bacterial infections effectively. Traditional microbiological diagnostics, involving initial culturing and subsequent pathogen detection, are often laborious and time-consuming. Even though modern techniques such as Raman spectroscopy, MALDI-TOF, and 16S rRNA PCR have significantly expedited this process, new methods are required for the accurate and fast detection of bacterial pathogens.

View Article and Find Full Text PDF

Comparative in vitro efficacy of AR-12 derivatives against Streptococcus pyogenes.

J Antimicrob Chemother

December 2024

Department of Medical Laboratory Science, I-Shou University, Kaohsiung City, Taiwan.

Objectives: Group A Streptococcus (GAS) results in invasive diseases. Our published studies show that AR-12 can directly kill GAS. However, AR-12 is toxic to the human microvascular endothelial cells (HMEC-1 cells) even at its MIC.

View Article and Find Full Text PDF

Mycobacterium tuberculosis is a human pathogen that causes Tuberculosis (TB) disease. Researchers have reported the activity of traditional medicinal plants against human pathogens. However, antimycobacterial studies of medicinal plants against M.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!